NovoCure Limited (NVCR)
USD 31.54
(-1.73%)
USD 31.54
(-1.73%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -73.33 Million | 30.78 Million | 82.75 Million | 99.14 Million | 26.62 Million | -1.86 Million |
| Net Income | -207.04 Million | -92.53 Million | -58.35 Million | 19.8 Million | -7.23 Million | -63.55 Million |
| Depreciation & Amortization | 10.96 Million | 10.62 Million | 10.25 Million | 9.15 Million | 8.46 Million | 9 Million |
| Deferred income taxes | 654 Thousand | - | 3.88 Million | -270 Thousand | -519 Thousand | 407 Thousand |
| Stock-based compensation | 115.6 Million | 106.95 Million | 94.9 Million | 75.72 Million | 52.41 Million | 39.84 Million |
| Change in working capital | 29.65 Million | 11.79 Million | 29.06 Million | -8.52 Million | -24.33 Million | 11.41 Million |
| Other non-cash items | -23.17 Million | -6.05 Million | 3 Million | 3.26 Million | -2.17 Million | 1.02 Million |
| Investing Cash Flow | 184.14 Million | -139.95 Million | -144.83 Million | -472.84 Million | -51.66 Million | -5.49 Million |
| Investments in PPE | -27.09 Million | -21.35 Million | -24.17 Million | -14.96 Million | -10.48 Million | -6.71 Million |
| Acquisitions | -211.24 Million | 118.59 Million | 120.66 Million | 457.87 Million | 41.18 Million | 3.79 Million |
| Investment purchases | -1 Billion | -1.29 Billion | -1.07 Billion | -607.87 Million | -461.84 Million | -253.78 Million |
| Sales/Maturities of investments | 1.21 Billion | 1.17 Billion | 958 Million | 150 Million | 420.66 Million | 255 Million |
| Other Investing Activities | 211.24 Million | -118.59 Million | -120.66 Million | -457.87 Million | -41.18 Million | -3.79 Million |
| Financing Cash Flow | 15.78 Million | 15.49 Million | 25.7 Million | 440.2 Million | 61.68 Million | 69.36 Million |
| Debt repayment | -10 Thousand | -28 Thousand | -26 Thousand | -150.02 Million | -31 Thousand | -100.08 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.41 Million | 5.22 Million | 4.54 Million | 3.37 Million | 2.46 Million | 1.83 Million |
| Other Financing Activities | 11.38 Million | 10.29 Million | 21.18 Million | 586.86 Million | 59.24 Million | 167.61 Million |
| Accounts receivables | 29.41 Million | 2.54 Million | 5.27 Million | -30.35 Million | -36.49 Million | -4.15 Million |
| Accounts payables | 14.86 Million | 14.25 Million | 27.77 Million | 25.47 Million | 16.88 Million | 9.5 Million |
| Inventory | -8.91 Million | -4.34 Million | 2.48 Million | -2.93 Million | -1.15 Million | -529 Thousand |
| Other working capital | -5.7 Million | -666 Thousand | -6.46 Million | -702 Thousand | -3.56 Million | 6.59 Million |
| Cash at beginning of period | 115.83 Million | 209.6 Million | 246.17 Million | 179.41 Million | 142.75 Million | 80.71 Million |
| Cash at end of period | 242.56 Million | 115.83 Million | 209.6 Million | 246.17 Million | 179.41 Million | 142.75 Million |
| Capital Expenditure | -27.09 Million | -21.35 Million | -24.17 Million | -14.96 Million | -10.48 Million | -6.71 Million |
| Effect of forex changes on cash | 131 Thousand | -97 Thousand | -188 Thousand | 247 Thousand | 26 Thousand | 27 Thousand |
| Net cash flow / Change in cash | 126.73 Million | -93.77 Million | -36.56 Million | 66.75 Million | 36.66 Million | 62.03 Million |
| Free Cash Flow | -100.42 Million | 9.43 Million | 58.58 Million | 84.18 Million | 16.13 Million | -8.57 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -30.57 Million | -33.37 Million | -38.76 Million | -207.04 Million | -47.07 Million | -49.48 Million |
| Depreciation & Amortization | 2.45 Million | 2.85 Million | 2.81 Million | 10.96 Million | 2.72 Million | 2.8 Million |
| Deferred income taxes | - | - | - | 654 Thousand | -1.9 Million | 1.51 Million |
| Stock-based compensation | 31.36 Million | 31.83 Million | 34.08 Million | 115.6 Million | 17.43 Million | 26.34 Million |
| Change in working capital | 15.12 Million | 3.02 Million | -26.76 Million | 29.65 Million | 22.15 Million | 5.72 Million |
| Other non-cash items | -8 Million | 31.16 Million | -3.75 Million | -23.17 Million | -7.88 Million | -6.21 Million |
| Investing Cash Flow | 10.19 Million | -374.44 Million | 246.21 Million | 184.14 Million | 98.5 Million | 17.25 Million |
| Investments in PPE | -10.68 Million | -11.44 Million | -11.78 Million | -27.09 Million | -6.82 Million | -7.25 Million |
| Acquisitions | - | - | - | -211.24 Million | -105.32 Million | -24.51 Million |
| Investment purchases | -169.12 Million | -522.99 Million | - | -1 Billion | -193.22 Million | -251.03 Million |
| Sales/Maturities of investments | 190 Million | 160 Million | 258 Million | 1.21 Billion | 298.54 Million | 275.54 Million |
| Other Investing Activities | - | -362.99 Million | 258 Million | 211.24 Million | 105.32 Million | 24.51 Million |
| Financing Cash Flow | 100 Thousand | 87.31 Million | 213 Thousand | 15.78 Million | 1.91 Million | 1.17 Million |
| Debt repayment | - | -84 Million | - | -10 Thousand | -10 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 100 Thousand | 3.3 Million | 213 Thousand | 4.41 Million | 1.53 Million | 1.17 Million |
| Other Financing Activities | 100 Thousand | 3.3 Million | 213 Thousand | 11.38 Million | 377 Thousand | 1.17 Million |
| Accounts receivables | 5.41 Million | -11.11 Million | -3.27 Million | 29.41 Million | 5.32 Million | 2.64 Million |
| Accounts payables | 7.45 Million | 9.54 Million | -18.24 Million | 14.86 Million | 18.86 Million | 6.26 Million |
| Inventory | 1.89 Million | 1.88 Million | -4.65 Million | -8.91 Million | -669 Thousand | -4.08 Million |
| Other working capital | 7.82 Million | 2.71 Million | -591 Thousand | -5.7 Million | -1.36 Million | -4.82 Million |
| Cash at beginning of period | 168.44 Million | 457.36 Million | 242.56 Million | 115.83 Million | 156.51 Million | 157.49 Million |
| Cash at end of period | 189.19 Million | 168.44 Million | 457.36 Million | 242.56 Million | 242.56 Million | 156.51 Million |
| Capital Expenditure | -10.68 Million | -11.44 Million | -11.78 Million | -27.09 Million | -6.82 Million | -7.25 Million |
| Effect of forex changes on cash | 87 Thousand | -77 Thousand | -56 Thousand | 131 Thousand | 200 Thousand | -97 Thousand |
| Net cash flow / Change in cash | 20.75 Million | -288.92 Million | 214.79 Million | 126.73 Million | 86.05 Million | -982 Thousand |
| Free Cash Flow | -307 Thousand | -13.16 Million | -43.35 Million | -100.42 Million | -21.37 Million | -26.56 Million |
ATHJF
WLDS
JIN
DMP
OPRX
APE